Vitality Watch

Dossier rss news report 09-sep-2026
Press coverage of research or of a longevity trend

Comparing the Responsiveness of Epigenetic Aging Biomarkers

Key claim: A recent study evaluated and compared how responsive several DNA methylation (DNAm) aging biomarkers are to a range of longevity interventions.

Abstract

In a recent study, researchers have evaluated how responsive several DNA methylation (DNAm) biomarkers are to a range of longevity […]

Why this matters

Choosing which epigenetic clock to run is not neutral: clocks differ in how much they move under the same intervention, and a ‘responsive’ clock may just be a noisier one. A head-to-head responsiveness comparison is the kind of methodological benchmarking this area needs before intervention trials can credibly claim to ‘lower biological age’ — but responsiveness is not the same as outcome validity, and movement in a clock is still not proof of de-aging.

Source

Link

Briefing card

Comparing the Responsiveness of Epigenetic Aging Biomarkers
Stage: news report · rss · 09-sep-2026

If you're picking a DNAm aging test to track an intervention, which clock you choose materially changes whether you'll see a response — and a bigger response isn't evidence the intervention worked.

A recent study evaluated and compared how responsive several DNA methylation (DNAm) aging biomarkers are to a range of longevity interventions.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://lifespan.io/comparing-the-responsiveness-of-epigenetic-aging-biomarkers/

build build 880 · 2bcef25 · 2026-11-18